Results 241 to 250 of about 148,658 (326)
Abstract Purpose Here we examine the association of anti‐inflammatory therapy with anatomical and functional outcomes of epiretinal membrane surgery. Methods The study included consecutive patients having gone through epiretinal membrane surgery at Helsinki University Hospital, Finland, between 2017 and 2021.
Pinja Sutinen+5 more
wiley +1 more source
Fedratinib-Associated Uveitis Effectively Treated With Sub-Tenon's Triamcinolone Acetonide Injection: A Case Report. [PDF]
Saitoh A+3 more
europepmc +1 more source
Hyperfluorescent dots in the ciliary body band in patients with granulomatous uveitis. [PDF]
R. Kimura
openalex +1 more source
One tube for all: 1‐year outcomes after transition to Paul glaucoma implant at a tertiary centre
Abstract Purpose To evaluate the intraocular pressure (IOP) lowering effect and success rate of Paul glaucoma implant (PGI) in refractory glaucoma after changing practice pattern from Ahmed and Baerveldt tubes to PGI. Methods A prospective observational study of the first 50 consecutive PGI surgeries at a single Danish tertiary centre from January 2022
Anne Studsgaard+2 more
wiley +1 more source
Bacterial endophthalmitis with lens capsule rupture and retinal detachment: A case report of <i>Rhizobium radiobacter</i> infection. [PDF]
Mizutani N+6 more
europepmc +1 more source
Cytotoxic Signature and IFN‐γ Production Dominate CD4+ T‐Cell Response During Human Toxoplasmosis
Overview of CD4+ T‐cell subsets in patients with toxoplasmosis. Schematic drawing summarising the most important alterations in CD4+ T‐cell subsets, illustrated in different colours, from patients in distinct stages of toxoplasmosis, represented with different colours, with (lesion) or without (no lesion) ocular manifestations.
Priscilla Miranda Henriques+14 more
wiley +1 more source
Minor salivary gland biopsy in the diagnosis of definite ocular sarcoidosis in paediatric granulomatous uveitis. [PDF]
Etchandy L+11 more
europepmc +1 more source
Objective This work aimed to evaluate the pharmacokinetics, efficacy, and safety of upadacitinib, an oral selective JAK inhibitor, in pediatric patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods In an open‐label, phase 1 study (SELECT‐YOUTH), enrolled patients, aged 2 to <18 years with pcJIA, received body weight–based ...
Hermine I. Brunner+12 more
wiley +1 more source